Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstr. 11, 80937 Munich, Germany.
Toxicol Lett. 2011 Sep 25;206(1):77-83. doi: 10.1016/j.toxlet.2011.07.006. Epub 2011 Jul 8.
Although the importance of atropine in therapy of organophosphate (OP) poisoning is generally recognized, its dosing is a matter of debate. A retrospective analysis of atropine dosing was undertaken in 34 patients who had been enrolled in a clinical study assessing obidoxime effectiveness in OP-poisoning. All patients were severely intoxicated (suicidal attempts) and required artificial ventilation. Atropine was administered routinely by intensive care physicians for life-threatening muscarinic symptoms, with the recommendation to favor low dosage. The pharmacological active enantiomere S-hyoscyamine was determined by a radioreceptor assay. When RBC-AChE activity ranged between 10% and 30%, S-hyoscyamine plasma concentrations of approx. 5 nmol L⁻¹ were sufficient. This concentration could be maintained with about 0.005 mg h⁻¹ kg⁻¹ atropine. Only when RBC-AChE was completely inhibited, therapy of cholinergic crisis required atropine doses up to 0.06 mg h⁻¹ kg⁻¹. Elimination half-life of S-hyoscyamine was 1.5 h, showing occasionally a second slow elimination phase with t(½)=12 h. Malignant arrhythmias were observed in some 10% of our cases, which occurred late and often in the absence of relevant glandular cholinergic signs, when the S-hyoscyamine concentration was below 2.5 nmol L⁻¹. Arrhythmias mostly resolved on reinstitution of atropine.
虽然阿托品在治疗有机磷(OP)中毒中的重要性已被普遍认可,但阿托品的剂量一直存在争议。我们对 34 名接受过肟类化合物治疗有机磷中毒有效性临床研究的患者进行了阿托品剂量回顾性分析。所有患者均为重度中毒(自杀企图),需要人工通气。根据重症监护医师的建议,为了避免危及生命的毒蕈碱样症状,应使用低剂量阿托品。采用放射受体测定法测定活性对映体 S-阿托品。当红细胞乙酰胆碱酯酶(RBC-AChE)活性在 10%至 30%之间时,S-阿托品的血浆浓度约为 5 纳摩尔/升即可。以 0.005 毫克/小时/千克的剂量使用阿托品即可维持这一浓度。只有当 RBC-AChE 完全被抑制时,治疗胆碱能危象才需要使用高达 0.06 毫克/小时/千克的阿托品。S-阿托品的消除半衰期为 1.5 小时,偶尔也会出现第二个缓慢消除阶段,半衰期为 12 小时。在我们的病例中,约有 10%观察到恶性心律失常,这些心律失常发生较晚,且常无相关腺体胆碱能迹象,此时 S-阿托品浓度低于 2.5 纳摩尔/升。心律失常大多在重新给予阿托品后得到解决。